Literature DB >> 22325766

Host glycan recognition by a pore forming toxin.

Samuel Bouyain1, Brian V Geisbrecht.   

Abstract

An exposed F-type lectin domain fused to the N-terminus of a cholesterol-dependent cytolysin scaffold allows Streptococcus mitis lectinolysin to cluster at fucose-rich sites on target cell membranes, thereby leading to increased pore-forming toxin activity. In this issue of Structure, Feil and coworkers define the structural basis for lectinolysin glycan-binding specificity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325766      PMCID: PMC3279720          DOI: 10.1016/j.str.2012.01.013

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  9 in total

Review 1.  Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins.

Authors:  Rodney K Tweten
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Blood group antigen recognition by a Streptococcus pneumoniae virulence factor.

Authors:  Alisdair B Boraston; Diana Wang; Robert D Burke
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

3.  Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65.

Authors:  H Ohkuni; Y Todome; F Okibayashi; Y Watanabe; N Ohtani; T Ishikawa; G Asano; S Kotani
Journal:  FEMS Immunol Med Microbiol       Date:  1997-02

4.  Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.

Authors:  Stephanie E Wickham; Eileen M Hotze; Allison J Farrand; Galina Polekhina; Tracy L Nero; Stephen Tomlinson; Michael W Parker; Rodney K Tweten
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

Review 5.  Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer.

Authors:  Elizabeth Yuriev; William Farrugia; Andrew M Scott; Paul A Ramsland
Journal:  Immunol Cell Biol       Date:  2005-12       Impact factor: 5.126

6.  A novel fucose recognition fold involved in innate immunity.

Authors:  Mario A Bianchet; Eric W Odom; Gerardo R Vasta; L Mario Amzel
Journal:  Nat Struct Biol       Date:  2002-08

7.  Characterization of a streptococcal cholesterol-dependent cytolysin with a lewis y and b specific lectin domain.

Authors:  Stephen Farrand; Eileen Hotze; Paul Friese; Susan K Hollingshead; David F Smith; Richard D Cummings; George L Dale; Rodney K Tweten
Journal:  Biochemistry       Date:  2008-06-14       Impact factor: 3.162

8.  Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.

Authors:  Kara S Giddings; Ji Zhao; Peter J Sims; Rodney K Tweten
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

9.  Structural basis of pore formation by the bacterial toxin pneumolysin.

Authors:  Sarah J Tilley; Elena V Orlova; Robert J C Gilbert; Peter W Andrew; Helen R Saibil
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

  9 in total
  3 in total

1.  Haemolytic actinoporins interact with carbohydrates using their lipid-binding module.

Authors:  Koji Tanaka; Jose M M Caaveiro; Koldo Morante; Kouhei Tsumoto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

2.  Functional dissection of Toxoplasma gondii perforin-like protein 1 reveals a dual domain mode of membrane binding for cytolysis and parasite egress.

Authors:  Marijo S Roiko; Vern B Carruthers
Journal:  J Biol Chem       Date:  2013-02-02       Impact factor: 5.157

Review 3.  F-Type Lectins: A Highly Diversified Family of Fucose-Binding Proteins with a Unique Sequence Motif and Structural Fold, Involved in Self/Non-Self-Recognition.

Authors:  Gerardo R Vasta; L Mario Amzel; Mario A Bianchet; Matteo Cammarata; Chiguang Feng; Keiko Saito
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.